Health
Moderna’s experimental COVID-19 vaccine induced immune response in all trial participants, says journal paper – CNA
US biotech firm Moderna said on Tuesday (Jul 14) it would enter the final stage of human trials for its COVID-19 vaccine on Jul 27, after promising early results were published in an influential journal.
WASHINGTON: US biotech firm Moderna said on Tuesday (Jul 14) it would enter the final stage of human trials for its COVID-19 vaccine on Jul 27, after promising early results were published in an influential journal.
Moderna was the first to start human testing of a vaccine for the novel coronavirus on Mar 16, about 66 days after the genetic sequence of the virus was released.
Advertisement
Advertisement
On Tuesday, the New England Journal of Medicine published results from the first stage of…
Continue Reading
